- Brand names:
- Pharmaceutical Company:
- Condition/Indication:
- Meeting Date: March 2018
- Public Summary Document (PSD) March 2018 PBAC Meeting - PDF
- Public Summary Document (PSD) March 2018 PBAC Meeting - Word
Asfotase alfa rch – March 2018
Asfotase alfa rch: Injection, 18 mg in 0.45 mL, 28 mg in 0.7 mL, 40 mg in 1 mL and 80 mg in 0.8 mL, vial; Strensiq®
Last updated
29 June 2018
